Menü
Das neue sharewise ist da Übersichtlicher, schneller, mit heller und dunkler Ansicht — und allem, was du kennst. Jetzt ausprobieren
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Suchergebnisse

SanDisk Slumps on Soft Guidance: Should You Buy the Dip With ETFs?
SanDisk Slumps on Soft Guidance: Should You Buy the Dip With ETFs?

SanDisk SNDK shares fell as much as 8% in after-hours trading on Aug. 5, 2026, after the flash memory and storage maker issued fiscal first-quarter revenue guidance that missed Wall Street

Is VLTO Worth Buying as Growth Improves but Valuation Stays Rich?
Is VLTO Worth Buying as Growth Improves but Valuation Stays Rich?

Veralto Corporation VLTO is showing better earnings momentum, resilient recurring revenues and ample liquidity. Those qualities strengthen the investment case as management expects growth to

Charles River Associates Q2 Earnings Call Highlights
Charles River Associates Q2 Earnings Call Highlights

Key Points

Should You Buy, Sell or Hold Eaton Stock Post Q2 Earnings?
Should You Buy, Sell or Hold Eaton Stock Post Q2 Earnings?

Eaton Corporation ETN posted solid second-quarter 2026 results, with both the top and bottom lines improving year over year as well as beating the Zacks Consensus Estimate. The quarter benefited

Should Investors Hold on to Astera Labs Stock Post Q2 Earnings?
Should Investors Hold on to Astera Labs Stock Post Q2 Earnings?

Astera Labs ALAB shares have lost 12% since it reported second-quarter 2026 results on Aug. 4, 2026.  The company’s second-quarter earnings suffered from higher operating expenses due to continued

Is ANGO a Buy as Med Tech Growth Battles Persistent Margin Pressure?
Is ANGO a Buy as Med Tech Growth Battles Persistent Margin Pressure?

AngioDynamics, Inc. ANGO offers investors a clear trade-off. Its Med Tech platforms are expanding quickly, but near-term earnings conversion remains weak as tariffs and operating costs absorb part

Avino Silver (ASM) Suffers a Larger Drop Than the General Market: Key InsightsPhoto, wide shot, wide-angle lens,  Gold mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/94faf2bd-99c1-4ea6-b55d-fdcab23c3865.png
Avino Silver (ASM) Suffers a Larger Drop Than the General Market: Key Insights

Avino Silver (ASM) ended the recent trading session at $6.38, demonstrating a -1.54% change from the preceding day's closing price. The stock's change was less than the S&P 500's daily loss of

Astrana Health Q2 Earnings Call Highlights
Astrana Health Q2 Earnings Call Highlights

Key Points

Assured Guaranty (AGO) Q2 Earnings Lag Estimates
Assured Guaranty (AGO) Q2 Earnings Lag Estimates

Assured Guaranty (AGO) came out with quarterly earnings of $1.23 per share, missing the Zacks Consensus Estimate of $1.66 per share. This compares to earnings of $1.01 per share a year ago. These

Trading Klaveness Com. Carriers As

Trading Klaveness Com. Carriers As

Klaveness Com. Carriers As diskutieren

Klaveness Com. Carriers As diskutieren

EQS-Adhoc: RHÖN-KLINIKUM Aktiengesellschaft: Asklepios Kliniken GmbH & Co. KGaA übermittelt Verlangen zur Durchführung eines Squeeze-out der Minderheitsaktionäre der RHÖN-Klinikum AktiengesellschaftPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
EQS-Adhoc: RHÖN-KLINIKUM Aktiengesellschaft: Asklepios Kliniken GmbH & Co. KGaA übermittelt Verlangen zur Durchführung eines Squeeze-out der Minderheitsaktionäre der RHÖN-Klinikum Aktiengesellschaft
EQS-Adhoc: RHÖN-KLINIKUM Aktiengesellschaft: Asklepios Kliniken GmbH & Co. KGaA übermittelt Verlangen zur Durchführung eines Squeeze-out der Minderheitsaktionäre der RHÖN-Klinikum Aktiengesellschaft
EQS-Adhoc: Asklepios Kliniken GmbH & Co. KGaA submits request for the implementation of a squeeze-out of the minority shareholders of RHÖN-Klinikum AktiengesellschaftPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
EQS-Adhoc: Asklepios Kliniken GmbH & Co. KGaA submits request for the implementation of a squeeze-out of the minority shareholders of RHÖN-Klinikum Aktiengesellschaft
EQS-Adhoc: Asklepios Kliniken GmbH & Co. KGaA submits request for the implementation of a squeeze-out of the minority shareholders of RHÖN-Klinikum Aktiengesellschaft
Genel Energy PLC: Response to announcement made by DNO ASAPhoto, wide shot, wide-angle lens,  Gas company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/01083d82-021d-4573-8c40-0e836a0771d6.png
Genel Energy PLC: Response to announcement made by DNO ASA
Genel Energy PLC: Response to announcement made by DNO ASA
4 Healthcare Stocks to Watch as Defensive Demand StrengthensPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
4 Healthcare Stocks to Watch as Defensive Demand Strengthens

The healthcare sector has quietly regained momentum in 2026, with the benchmark State Street Health Care Select Sector SPDR ETF (XLV) advancing 7.1% year to date as of Aug. 6. Investors have

Net Asset Value(s)
Net Asset Value(s)
Net Asset Value(s)
Manhattan Associates (MANH) Now Trades Above Golden Cross: Time to Buy?
Manhattan Associates (MANH) Now Trades Above Golden Cross: Time to Buy?

Manhattan Associates, Inc. (MANH) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, MANH's 50-day simple moving average broke out

Is AGC Inc. - Unsponsored ADR (ASGLY) Stock Outpacing Its Conglomerates Peers This Year?
Is AGC Inc. - Unsponsored ADR (ASGLY) Stock Outpacing Its Conglomerates Peers This Year?

Investors interested in Conglomerates stocks should always be looking to find the best-performing companies in the group. Has AGC Inc. - Unsponsored ADR (ASGLY) been one of those stocks this year

Down 10.2% in 4 Weeks, Here's Why You Should You Buy the Dip in American Assets Trust (AAT)
Down 10.2% in 4 Weeks, Here's Why You Should You Buy the Dip in American Assets Trust (AAT)

A downtrend has been apparent in American Assets Trust (AAT) lately with too much selling pressure. The stock has declined 10.2% over the past four weeks. However, given the fact that it is now in

ATI Q2 Earnings Call Highlights AA&S Margin Growth and '26 Outlook: https://staticx-tuner.zacks.com/images/articles/main/30/172914.webp
ATI Q2 Earnings Call Highlights AA&S Margin Growth and '26 Outlook

ATI Inc. ATI used its second-quarter call to frame Advanced Alloys & Solutions as a stronger earnings contributor, while reaffirming High Performance Materials & Components as its main long-term